NCT05741580View on ClinicalTrials.gov

Peri-urethral Bulk Agent Injection of Bulkamid®

CompletedOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

October 1, 2022

Primary Completion Date

November 30, 2022

Study Completion Date

December 31, 2022

Conditions
Peri-urethral Bulk Agent Injection of Bulkamid® for Urinary Incontinence
Interventions
PROCEDURE

Evolution of symptoms

percentage of patients with improvement in their symptoms

Trial Locations (1)

69500

Service de Gynécologie, HFME, Hospices Civils de Lyon, Bron

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER